We start with a technology demonstration workshop between our lead developers and clients.

We sign Non-Disclosures, and relevant agreements.

Clients provide a Request for Quote (RFQ) OR Request for Proposal (RFP).

We work with clients to obtain necessary information – to scope and cost the project/s and services.

We submit to clients the full-service level agreement (SLA) and quotation (to be co-reviewed AND co-signed).

We execute the project AND services within the timeframe agreed.

We provide report and project intelligence packages to clients.

We receive official feedback from clients.

We provide the final report and close the project AND services.

We keep our clients informed about new technological capabilities and important benefits.

Scientific literature suggests that there is a plethora of biological molecules whose identity and characteristics are unknown

The process of finding biomolecules with identifiable, classifiable and characterizable capabilities remains largely a wet laboratory approach

The costs associated with finding a biomolecule that passes clinical evaluation is too high, associated with marginal chances of getting through the process

The new and rising cases of both novel communicable and non-communicable diseases pose a threat to the world, with newer and novel health-related biomolecules being highly sought after

Regardless of newer AI technologies that assist to leapfrog some of these challenges, there are limited AI-backed convergence tools that guarantee over 80% success